ripekg:retraction-notice/67438Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1080%2F09513590.2017.1290071 |
ripekg:retraction-notice/67438Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:work/10.1080%2F09513590.2017.1290071 |
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
http://purl.org/spar/cito/retracts |
ripekg:work/10.1080%2F09513590.2017.1290071 |
ripekg:retraction-notice/67439Oral carnitine supplementation influences mental health parameters and biomarkers of oxidative stress in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial |
ripe:concerns |
ripekg:work/10.1080%2F09513590.2017.1290071 |
ripekg:work/10.1080%2F09513590.2017.1290071 |
prism:doi |
10.1080/09513590.2017.1290071 |
ripekg:work/10.1080%2F09513590.2017.1290071 |
prism:publicationDate |
2017-02-21 |
ripekg:work/10.1080%2F09513590.2017.1290071 |
rdf:type |
node1 |
ripekg:work/10.1080%2F09513590.2017.1290071 |
rdf:type |
http://purl.org/spar/fabio/Work |
ripekg:work/10.1080%2F09513590.2017.1290071 |
rdf:type |
rdfs:Resource |
ripekg:work/10.1080%2F09513590.2017.1290071 |
rdf:type |
owl:Thing |
ripekg:work/10.1080%2F09513590.2017.1290071 |
rdf:type |
prov:Entity |
ripekg:work/10.1080%2F09513590.2017.1290071 |
rdf:type |
ripe:WorkWork |
ripekg:work/10.1080%2F09513590.2017.1290071 |
owl:sameAs |
https://semopenalex.org/work/W2591165579 |